Publications

Lost funding, unwelcome moves: UK researchers speak out on ERC ‘disaster’.

Authors: C Woolston

Research group: Markowetz Group

E-pub date: 31 Aug 2022

Journal name: Nature

Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis.

Authors: C Pesenti, L Beltrame, A Velle, R Fruscio, M Jaconi, F Borella, FM Cribiù,...

Research group: Brenton Group

E-pub date: 31 Aug 2022

Journal name: Eur J Cancer

Challenges and opportunities for physician-scientists in advancing cancer research.

Authors: NE Davidson, RJ Gilbertson, A Letai, RL Levine, F McAllister, LL Siu

Research group: Gilbertson Group

E-pub date: 31 Aug 2022

Journal name: Trends Cancer

Noninvasive hemoglobin sensing and imaging: optical tools for disease diagnosis.

Authors: M Taylor-Williams, G Spicer, G Bale, SE Bohndiek

Research group: Bohndiek Group

E-pub date: 31 Aug 2022

Journal name: J Biomed Opt

Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy.

Authors: AR Hanby, SJ Walsh, AJ Counsell, N Ashman, KT Mortensen, JS Carroll, DR Spr...

Research group: Carroll Group

E-pub date: 18 Aug 2022

Journal name: Chem Commun (Camb)

Metabolic Glycan Labeling of Cancer Cells Using Variably Acetylated Monosaccharides.

Authors: DR Parle, F Bulat, S Fouad, H Zecchini, KM Brindle, AA Neves, FJ Leeper

Research group:

E-pub date: 17 Aug 2022

Journal name: Bioconjug Chem

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.

Authors: CM Sauer, K Heider, J Belic, SE Boyle, JA Hall, D-L Couturier, A An, A Vija...

Research group: Brenton Group,

E-pub date: 8 Aug 2022

Journal name: EMBO Mol Med

Relationships between genome-wide R-loop distribution and classes of recurrent DNA breaks in neural stem/progenitor cells.

Authors: S Thongthip, A Carlson, MP Crossley, B Schwer

Research group: Crossley Group

E-pub date: 4 Aug 2022

Journal name: Sci Rep

Filters

Research Groups

Core Facilities

Start date

End date

Lost funding, unwelcome moves: UK researchers speak out on ERC ‘disaster’.

Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis.

Challenges and opportunities for physician-scientists in advancing cancer research.

Noninvasive hemoglobin sensing and imaging: optical tools for disease diagnosis.

Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy.

Metabolic Glycan Labeling of Cancer Cells Using Variably Acetylated Monosaccharides.

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.

Relationships between genome-wide R-loop distribution and classes of recurrent DNA breaks in neural stem/progenitor cells.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Lost funding, unwelcome moves: UK researchers speak out on ERC ‘disaster’.

Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis.

Challenges and opportunities for physician-scientists in advancing cancer research.

Noninvasive hemoglobin sensing and imaging: optical tools for disease diagnosis.

Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy.

Metabolic Glycan Labeling of Cancer Cells Using Variably Acetylated Monosaccharides.

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.

Relationships between genome-wide R-loop distribution and classes of recurrent DNA breaks in neural stem/progenitor cells.